Display Settings:

Format

Send to:

Choose Destination
    J Immunol. 1992 Jan 1;148(1):234-8.

    A nontoxic, idiotope vaccine against gram-negative bacterial infections.

    Source

    Department of Molecular Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263.

    Abstract

    Experiments were performed to test the ability of mouse antiidiotopic mAb, specific for an antilipid A mAb, to act as a vaccine against gram-negative bacterial infections. Lipid A is a conserved region of bacterial LPS. Immunization with the antiidiotopic antibodies, coupled to an immunogenic carrier protein (hemocyanin), specifically induced anti-LPS antibody responses in animals from different species. In a mouse model, this immunization resulted in protection against both lethal gram-negative bacteremia and endotoxemia. The antiidiotopic antibodies, however, did not stimulate endotoxin-associated bioactivities, such as induction of TNF and IL-1. These results support the hypothesis that an idiotope vaccine can stimulate beneficial protective immunity against gram-negative infections without the toxicity inherent in LPS.

    PMID:
    1727868
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Chemical compound information

      • Chemical compound molecule image Lipid A
        MW: 1798.36 g/mol
        MF: C94H178N2O25P2
      See 2 citations for this compound....

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk